Identification and validation of core oxidative phosphorylation-related genes as biomarkers for immune response and diagnosis in burn injury - Report - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Discovery and validation of essential oxidative phosphorylation-associated genes as indicators for immune response and diagnostic purposes in burn injuries
Clinical Report: Essential Oxidative Phosphorylation-Associated Genes in Burn Injuries
Overview
This study identifies 23 oxidative phosphorylation-related genes as potential biomarkers for immune response in burn injuries. Three core genes, ATP6V1C1, ECHS1, and LDHA, were validated for their roles in immune modulation.
Background
Burn injuries are a major global health issue, leading to severe trauma and significant systemic inflammatory responses. The identification of reliable biomarkers for early diagnosis and assessment of burn severity is critical.
Data Highlights
Gene
Role
ATP6V1C1
Involved in early immune response
ECHS1
Modulates immune cell function
LDHA
Involved in early immune response
Key Findings
Identification of 23 differentially expressed oxidative phosphorylation-related genes in burn patients.
Core genes ATP6V1C1, ECHS1, and LDHA are associated with burn progression.
Group A patients showed heightened immune activity compared to Group B patients.
Knockdown of ATP6V1C1 or LDHA reduced pro-inflammatory cytokine secretion.
A diagnostic nomogram based on core genes demonstrated diagnostic capability.
Clinical Implications
The identified core genes may serve as potential molecular targets for enhancing prognosis in burn patients.
Conclusion
This study highlights oxidative phosphorylation-associated genes as biomarkers for immune response in burn injuries.